NCT04598659

Brief Summary

This feasibility study is being conducted to investigate the practicalities and potential benefits of equipping patients with wearable monitoring devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 22, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

January 6, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2022

Completed
Last Updated

January 29, 2024

Status Verified

January 1, 2024

Enrollment Period

1 year

First QC Date

October 16, 2020

Last Update Submit

January 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient compliance

    The percentage of all participating patients for whom a complete and unbroken record of their vital signs is obtained throughout the duration of the agreed monitoring period.

    7 days (the monitoring period)

Secondary Outcomes (3)

  • Device comfort assessed by a 5-point rating scale

    15 minutes

  • Convenience of remote monitoring assessed by a 5-point rating scale

    15 minutes

  • The average time required to support patients through the remote monitoring process

    6 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will include patients who present themselves for care or consultation at the Northampton General Hospital during the period of the study.

You may qualify if:

  • The participant is able to provide informed consent.
  • The participant is able to comply with the English instructions for using a wearable device (e.g, follow simple instructions, able to answer the telephone, able to answer symptom questions, etc.).
  • The participant may have been recently discharged from a hospital care setting (including emergency departments, ward and acute assessment units) to home (including a relative's home) or be currently admitted to a hospital care setting.
  • The participant has a recent medical history that suggests there is a risk their health may deteriorate at home. In the first instance we will focus upon patients with at least one of the following conditions:
  • Heart Failure (the patient being discharged),
  • Arrhythmia (e.g. patient on the waitlist for a pacemaker)
  • We will also consider patients with other conditions that present a risk of deterioration at home, for example: COPD, stable angina, liver failure, minor trauma, chronic kidney disease, stroke, hypertension, cancer ( e.g. recent surgery)

You may not qualify if:

  • Patients that are clinically unstable (eg: respiratory distress, ongoing angina pectoris, sepsis, etc).
  • Aphasia or other conditions that prevents the patient from adequately communicating with the researchers.
  • Terminal diagnosis with life expectancy \< 3 months.
  • Ongoing renal dialysis, or other treatment that prevents the patient from being at home for extended periods.
  • Dementia or uncontrolled psychiatric illness.
  • Severe dermatitis or another skin disorder that prevents the patient from wearing a patch.
  • Patient has a pacemaker or ICD
  • Other inability, or unwillingness, to adequately co-operate with the RPM-team.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northampton General Hospital

Northampton, United Kingdom

Location

MeSH Terms

Conditions

Heart FailureCardiovascular DiseasesRespiration DisordersStroke

Condition Hierarchy (Ancestors)

Heart DiseasesRespiratory Tract DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular Diseases

Study Officials

  • David Sharman

    Northampton General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Investigator

Study Record Dates

First Submitted

October 16, 2020

First Posted

October 22, 2020

Study Start

January 6, 2021

Primary Completion

January 6, 2022

Study Completion

March 6, 2022

Last Updated

January 29, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations